Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Tuberculosis, Pulmonary: early-phase trial registry
A small indexed set (4 trials) with no open enrollment listed right now.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · none currently recruiting · #4,115 of 28,707 conditions by registered trial count
Tuberculosis, Pulmonary: 4 US clinical trials tracked, none currently recruiting.
Tuberculosis, Pulmonary is the subject of 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Global Alliance for TB Drug Development, running 2 of these trials.
Enrollment posture brief
Registry condition tuberculosis-pulmonary
OPEN 0 | RECR 0% | LATE 0 | EARLY 3 | RANK #4115 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Tuberculosis, Pulmonary has no open enrollment in this registry pull (4 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Tuberculosis, Pulmonary on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Tuberculosis, Pulmonary is recruiting below its size-band peers.
0 of 4 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Short-course Regimens for the Treatment of Pulmonary Tuberculosis
Centers for Disease Control and Prevention
NCT05766267
Tuberculosis - Learning the Effect of Parasites and Reinforcing Diets
Boston Medical Center
NCT05048485
A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults
Global Alliance for TB Drug Development
NCT05526911
Study to Evaluate Safety, Tolerability, and the PK Profile of TBI-223 in Healthy Subjects
Global Alliance for TB Drug Development
NCT04865536
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Tuberculosis, Pulmonary records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Tuberculosis, Pulmonary trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Tuberculosis, Pulmonary page
4 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Tuberculosis, Pulmonary trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Global Alliance for TB Drug Development sponsors the most Tuberculosis, Pulmonary trials on record, review their full trial history before evaluating a specific study. See Global Alliance for TB Drug Development's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Tuberculosis, Pulmonary condition card totals 4 registered trials; most-linked intervention TBI-223 Placebo; top US site state New Jersey. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.